시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 알부민 및 크레아티닌 검사 시장 보고서(2025년)
Albumin And Creatinine Tests Global Market Report 2025
상품코드 : 1720703
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,342,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,167,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,992,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

알부민 및 크레아티닌 검사 시장 규모는 향후 수년간 비약적인 성장이 전망될 예정입니다. 예측 기간의 성장은 가정 및 원격 진단 솔루션에 대한 수요 증가, 정밀 검사를위한 진단 도구의 AI 통합 증가, 예방 건강 관리 및 질병 조기 발견의 중요성 증가, 개인화된 의료 접근 치의 확대, 신장의 건강 의식 향상 프로그램을 지원하는 정부의 대처에 기인한다고 생각됩니다. 주요 동향으로서는 자동화된 휴대용 진단 시스템의 개발, 원격 의료 대응의 진단 솔루션의 채용 확대, 보다 정확한 신기능 검사를 위한 바이오마커의 진보, 현장 용도의 랩 칩 기술의 성장, 진단 기업과 연구 기관

만성 신장병의 유병률 증가는 알부민 및 크레아티닌 검사 시장의 성장을 이끌 것으로 예측됩니다. 신장의 기능이 손상되는 것을 특징으로하는 진행성 질환입니다. 이것은 독소 축적과 다양한 신체계에서 합병증을 일으킬 수 있습니다. CKD의 이환율 증가는 당뇨병, 고혈압, 비만 등 위험 인자 증가로 인한 곳이 큽니다. CKD의 진단과 모니터링에 중요한 역할을 하고 있습니다.이 검사를 통해 신장 장애의 조기 발견과 관리가 가능합니다. 예를 들어, 2023년 6월 영국에 본사를 둔 비영리 단체인 영국 신장 연구(Kidney Research UK)는 영국 인구의 10% 이상인 약 720만 명(진행 단계 325만 명, 초기 단계 390만 명 포함)이 만성 신장 질환을 앓고 있다고 보고했습니다. 2033년까지 761만명으로 증가할 것으로 예상되고 있으며, 그 결과 만성 신장병의 이환율 상승이 알부민 및 크레아티닌 검사 시장의 성장에 박차를 가하고 있습니다.

이 시장의 주요 기업은 소변 샘플을 분석하여 환자의 알부민/크레아티닌 비율을 측정하여 신장병의 검출을 강화하기 위해 스마트폰 기반 검사 등의 혁신적인 기술에 주력하고 있습니다. 모바일 기술을 활용하여 진단 검사를 실시하고 건강 데이터를 분석함으로써 빠르고 편리한 결과를 제공합니다. 예를 들어, 2022년 7월 영국에 본사를 둔 의료 기술 회사인 Healthy.io는 미국 식품의약국(FDA)으로부터 AI 기반 스마트폰 진단 도구인 Minuteful Kidney Test의 승인을 받았습니다. 비침습적이고 사용자 친화적인 이 검사는 스마트폰과 전용 검사 스트립만 있으면 환자가 집에서 검사를 수행할 수 있으며, 실시간으로 결과를 확인할 수 있습니다. 신장 질환을 조기에 발견할 수 있어 환자가 자신의 건강을 모니터링하고 적시에 의료 개입을 받을 수 있어 병원에 자주 방문할 필요성을 줄일 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Albumin and creatinine tests measure the concentrations of these two substances in urine samples to provide a more accurate assessment of kidney health. By calculating the albumin-to-creatinine ratio, the test accounts for fluctuations in creatinine levels caused by factors such as hydration status.

The main product types for these tests include dipsticks and kits, analyzers, cartridges, reagents, and others. Dipsticks and kits play a crucial role in detecting albuminuria, a key indicator of chronic kidney disease. The different test types include blood and urine creatinine, urine albumin, and glycated albumin. These tests are utilized by various end users, including hospitals and clinics, diagnostic laboratories, research laboratories and institutes, and other healthcare facilities.

The albumin and creatinine tests market research report is one of a series of new reports from The Business Research Company that provides albumin and creatinine tests market statistics, including albumin and creatinine tests industry global market size, regional shares, competitors with an albumin and creatinine tests market share, detailed albumin and creatinine tests market segments, market trends and opportunities, and any further data you may need to thrive in the albumin and creatinine tests industry. This albumin and creatinine tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The albumin and creatinine tests market size has grown exponentially in recent years. It will grow from $2.95 billion in 2024 to $3.61 billion in 2025 at a compound annual growth rate (CAGR) of 22.6%. The growth in the historic period can be attributed to the rising prevalence of chronic kidney disease (CKD) and diabetes, increased awareness of early diagnostic tools for renal health, greater adoption of point-of-care testing devices, expanding healthcare infrastructure in emerging markets, and advancements in diagnostic testing technologies.

The albumin and creatinine tests market size is expected to see exponential growth in the next few years. It will grow to $8.05 billion in 2029 at a compound annual growth rate (CAGR) of 22.2%. The growth in the forecast period can be attributed to the rising demand for home-based and remote diagnostic solutions, increased integration of AI in diagnostic tools for precision testing, a growing emphasis on preventive healthcare and early disease detection, the expansion of personalized medicine approaches, and government initiatives supporting kidney health awareness programs. Key trends include the development of automated and portable diagnostic systems, greater adoption of telemedicine-enabled diagnostic solutions, advancements in biomarkers for more accurate renal function testing, the growth of lab-on-chip technologies for point-of-care applications, and increasing collaborations between diagnostic companies and research institutions.

The increasing prevalence of chronic kidney diseases is expected to drive the growth of the albumin and creatinine tests market. Chronic kidney disease (CKD) is a progressive condition characterized by the gradual decline of kidney function, impairing the kidneys' ability to effectively filter waste and excess fluids from the blood. This can lead to toxin buildup and complications in various bodily systems. The growing incidence of CKD is largely attributed to rising risk factors such as diabetes, hypertension, and obesity. Albumin and creatinine tests play a crucial role in diagnosing and monitoring CKD by measuring protein levels, particularly albumin, in urine and assessing kidney function through creatinine levels. These tests enable early detection and management of kidney damage. For example, in June 2023, Kidney Research UK, a UK-based non-profit organization, reported that approximately 7.2 million people in the UK, over 10% of the population are living with chronic kidney disease, including 3.25 million in advanced stages and 3.9 million in early stages. This number is projected to increase to 7.61 million by 2033. Consequently, the rising incidence of chronic kidney disease is fueling the growth of the albumin and creatinine tests market.

Leading companies in the market are focusing on innovative technologies, such as smartphone-based testing, to enhance kidney disease detection by analyzing urine samples and determining a patient's albumin-to-creatinine ratio. Smartphone-based testing utilizes mobile technology, including apps and external devices, to conduct diagnostic tests and analyze health data, providing quick and convenient results. For instance, in July 2022, Healthy.io, a UK-based health technology company, received approval from the U.S. Food and Drug Administration (FDA) for its Minuteful Kidney Test, an AI-powered smartphone diagnostic tool. This non-invasive, user-friendly test allows patients to perform the test at home using just a smartphone and a specialized test strip, delivering real-time results. By enabling early detection of kidney disease, it empowers patients to monitor their health and seek timely medical intervention, potentially reducing the need for frequent doctor visits.

In September 2022, Sartorius AG, a Germany-based biotech research company, acquired Albumedix for $502 million. This acquisition aims to strengthen Sartorius's production capabilities by expanding its portfolio with recombinant albumin, which is used in various biomanufacturing applications, including as an animal-free supplement to cell culture media and as a stabilizer for vaccines and viral treatments. Albumedix Ltd., a UK-based company, specializes in the development and commercialization of advanced therapies.

Major players in the albumin and creatinine tests market are Siemens Healthineers Company, Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, FUJIFILM Corporation, Laboratory Corporation of America Holdings, Sysmex Corporation, Ortho Clinical Diagnostics Inc., Randox Laboratories Ltd., Nova Biomedical Corporation, Eagle Biosciences Inc., Sekisui Diagnostics LLC, BTNX Inc., RayBiotech Life Inc., ARKRAY Inc., PromoCell GmbH, Arbor Assays Inc., Teco Diagnostics Inc., J. Mitra & Co. Pvt. Ltd., Anamol Laboratories Pvt. Ltd.

North America was the largest region in the albumin and creatinine tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in albumin and creatinine tests report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the albumin and creatinine tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The albumin and creatinine tests market consists of revenues earned by entities by providing services such as diagnostic testing services, home testing kits, automated test solutions, and data analysis and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The albumin and creatinine tests market also includes sales of reagents and consumables, testing instruments, home test kits, and software solutions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Albumin And Creatinine Tests Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on albumin and creatinine tests market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for albumin and creatinine tests ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The albumin and creatinine tests market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Albumin And Creatinine Tests Market Characteristics

3. Albumin And Creatinine Tests Market Trends And Strategies

4. Albumin And Creatinine Tests Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Albumin And Creatinine Tests Growth Analysis And Strategic Analysis Framework

6. Albumin And Creatinine Tests Market Segmentation

7. Albumin And Creatinine Tests Market Regional And Country Analysis

8. Asia-Pacific Albumin And Creatinine Tests Market

9. China Albumin And Creatinine Tests Market

10. India Albumin And Creatinine Tests Market

11. Japan Albumin And Creatinine Tests Market

12. Australia Albumin And Creatinine Tests Market

13. Indonesia Albumin And Creatinine Tests Market

14. South Korea Albumin And Creatinine Tests Market

15. Western Europe Albumin And Creatinine Tests Market

16. UK Albumin And Creatinine Tests Market

17. Germany Albumin And Creatinine Tests Market

18. France Albumin And Creatinine Tests Market

19. Italy Albumin And Creatinine Tests Market

20. Spain Albumin And Creatinine Tests Market

21. Eastern Europe Albumin And Creatinine Tests Market

22. Russia Albumin And Creatinine Tests Market

23. North America Albumin And Creatinine Tests Market

24. USA Albumin And Creatinine Tests Market

25. Canada Albumin And Creatinine Tests Market

26. South America Albumin And Creatinine Tests Market

27. Brazil Albumin And Creatinine Tests Market

28. Middle East Albumin And Creatinine Tests Market

29. Africa Albumin And Creatinine Tests Market

30. Albumin And Creatinine Tests Market Competitive Landscape And Company Profiles

31. Albumin And Creatinine Tests Market Other Major And Innovative Companies

32. Global Albumin And Creatinine Tests Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Albumin And Creatinine Tests Market

34. Recent Developments In The Albumin And Creatinine Tests Market

35. Albumin And Creatinine Tests Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기